Humana Inc. $HUM Shares Acquired by Fisher Funds Management LTD

Fisher Funds Management LTD boosted its holdings in Humana Inc. (NYSE:HUM) by 43.1% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 79,282 shares of the insurance provider’s stock after purchasing an additional 23,867 shares during the quarter. Fisher Funds Management LTD owned about 0.07% of Humana worth $20,627,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA boosted its holdings in shares of Humana by 273.2% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,488,261 shares of the insurance provider’s stock valued at $907,541,000 after buying an additional 2,553,509 shares in the last quarter. Norges Bank purchased a new stake in Humana in the second quarter valued at $397,079,000. Leith Wheeler Investment Counsel Ltd. lifted its position in Humana by 661.7% in the second quarter. Leith Wheeler Investment Counsel Ltd. now owns 1,038,703 shares of the insurance provider’s stock valued at $253,942,000 after acquiring an additional 902,340 shares during the last quarter. Dodge & Cox boosted its stake in Humana by 5.6% in the second quarter. Dodge & Cox now owns 11,352,920 shares of the insurance provider’s stock valued at $2,775,562,000 after acquiring an additional 597,705 shares in the last quarter. Finally, 8 Knots Management LLC grew its holdings in shares of Humana by 671.0% during the second quarter. 8 Knots Management LLC now owns 441,623 shares of the insurance provider’s stock worth $107,968,000 after purchasing an additional 384,345 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Price Performance

Shares of NYSE HUM opened at $273.02 on Tuesday. The stock has a fifty day moving average price of $256.03 and a 200 day moving average price of $264.01. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $315.35. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.02 and a quick ratio of 2.02. The company has a market cap of $32.84 billion, a PE ratio of 25.59, a P/E/G ratio of 2.25 and a beta of 0.45.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. Humana had a net margin of 1.02% and a return on equity of 12.86%. The company had revenue of $32.65 billion during the quarter, compared to the consensus estimate of $31.99 billion. During the same quarter in the prior year, the firm earned $4.16 EPS. Humana’s quarterly revenue was up 11.1% on a year-over-year basis. Sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, December 26th. This represents a $3.54 annualized dividend and a yield of 1.3%. Humana’s payout ratio is presently 33.18%.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Guggenheim reissued a “buy” rating on shares of Humana in a research report on Friday, October 3rd. Jefferies Financial Group upgraded Humana from a “hold” rating to a “buy” rating and boosted their price objective for the company from $253.00 to $313.00 in a research note on Friday, December 5th. KeyCorp restated a “sector weight” rating on shares of Humana in a research report on Friday, December 12th. Robert W. Baird reduced their price target on shares of Humana from $280.00 to $264.00 and set a “neutral” rating for the company in a research report on Thursday, December 11th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a research note on Wednesday, October 8th. Eight investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Humana presently has a consensus rating of “Hold” and an average price target of $293.37.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.